Combine RNAseq and scRNAseq data with other omics data types (e.g., genomics, proteomics) using ML/DL to provide a comprehensive understanding of the molecular drivers of cancer.
a) Precision medicine
b) Systems biology
c) Epidemiology
d) Pharmacogenomics